INREBIC

Product Overview

About INREBIC

INREBIC is a medicine that contains the active ingredient FEDRATINIB (FEDRATINIB HYDROCHLORIDE), which is used to treat certain medical conditions. It is essential to use INREBIC under the guidance of a healthcare professional to ensure safe and effective treatment. INREBIC is designed to provide relief from specific symptoms and improve the quality of life for patients with particular diseases.

Key Benefits & Uses

• Treatment of intermediate-2 or high-risk primary myelofibrosis
• Treatment of secondary myelofibrosis with myeloid metaplasia
• Relief from symptoms such as fatigue, abdominal discomfort, and spleen enlargement

Active Ingredient & Action

FEDRATINIB (FEDRATINIB HYDROCHLORIDE) works by inhibiting the activity of certain enzymes involved in the development and progression of myelofibrosis. By reducing the abnormal growth of blood cells, FEDRATINIB helps to alleviate symptoms and improve blood cell counts, ultimately enhancing the patient's overall well-being.

Important Notes

Patients should follow the prescribed dosage and administration instructions for INREBIC, and inform their healthcare provider about any existing medical conditions or medications. Regular monitoring of blood cell counts, liver function, and other vital signs is crucial during treatment with INREBIC. It is also essential to discuss potential side effects and any concerns with a healthcare professional to ensure safe and effective treatment.